Fremanezumab May Reduce Attacks in Tough-to-Treat Migraine Fremanezumab May Reduce Attacks in Tough-to-Treat Migraine

The CGRP-targeting migraine-prevention drug fremanezumab is safe and effective in reducing migraines for patients who have failed up to four other therapies, new research shows.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news